Oxford BioDynamics (LON:OBD) Stock Price Passes Below 50 Day Moving Average – Should You Sell?
by Scott Moore · The Cerbat GemOxford BioDynamics Plc (LON:OBD – Get Free Report) shares crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of GBX 0.27 and traded as low as GBX 0.24. Oxford BioDynamics shares last traded at GBX 0.24, with a volume of 11,003,255 shares traded.
Oxford BioDynamics Price Performance
The company has a market capitalization of £9.87 million, a P/E ratio of -0.29 and a beta of 0.42. The business’s 50-day simple moving average is GBX 0.27 and its 200 day simple moving average is GBX 0.33. The company has a current ratio of 0.88, a quick ratio of 2.80 and a debt-to-equity ratio of 457.97.
Oxford BioDynamics (LON:OBD – Get Free Report) last announced its earnings results on Wednesday, December 24th. The biotechnology company reported GBX (0.80) EPS for the quarter. Oxford BioDynamics had a negative net margin of 1,018.54% and a negative return on equity of 316.67%.
About Oxford BioDynamics
Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.
Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.
In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.